🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 3 study to evaluate the efficacy and safety of subcutaneous tildrakiz...
Status
Active Not Recruiting
Location
Smary Cures Clinical Research
Start Date
2025-03-21
Trial ID
NCT06611163
Treatments Being Tested
This is a phase Ⅲ, randomized, double-blind, placebo-controlled, parallel d...
Status
Completed
Location
The First Affiliated Hospital of Air Force Medical University of PLA
Start Date
2020-12-17
Trial ID
NCT05108766
Treatments Being Tested
This is a randomized, double-Blind, placebo-controlled Phase 2a study to ev...
Status
Terminated
Location
SPARC Site 1
Start Date
2017-11-06
Trial ID
NCT02980705
Treatments Being Tested
This is a randomized, double-blinded, placebo-controlled, Phase 3 study to ...
Status
Active Not Recruiting
Location
Sunpharma site no. 12
Start Date
2020-07-01
Trial ID
NCT04314531
Treatments Being Tested
The study has been designed with three components. Part A is an open label ...
Status
Active Not Recruiting
Location
Site 1
Start Date
2020-01-15
Trial ID
NCT03997786
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
This is a multicenter, randomized, double-blind, placebo-controlled study t...
Status
Completed
Location
SPARC Site 18
Start Date
2019-03-29
Trial ID
NCT03897088
Treatments Being Tested
This is a multicenter Phase III, Randomized, Double-Blind, Single-Dose, Pla...
Status
Completed
Location
Sunpharma Site no 42
Start Date
2020-07-01
Trial ID
NCT04314544
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multiple-dose, phas...
Status
Completed
Location
SPARC Site 1
Start Date
2017-04-19
Trial ID
NCT02980692
Treatments Being Tested
This study is being conducted to evaluate the efficacy and safety/tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-05
Trial ID
NCT01729754